Pro-oxidant Phytocompounds and Mitochondrial Vulnerabilities: A Novel Paradigm in Cancer Therapy

Open Access

Issue		BIO Web Conf. Volume 233, 2026 9^th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)


Article Number		01020
Number of page(s)		14
Section		Biomedical and Health Innovations
DOI		https://doi.org/10.1051/bioconf/202623301020
Published online		23 April 2026

Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I. and Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. [Google Scholar]
Snezhkina, A.V. et al. (2019). ROS generation and antioxidant defense systems in normal and malignant cells. Oxidative Medicine and Cellular Longevity, 2019, 6175804. [Google Scholar]
Gao, Q., Zhu, X., Chen, M., Xia, R. and Zhang, Q. (2025). Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors. Frontiers in Immunology, 16, 1541675. [Google Scholar]
Jomova, K., Alomar, S.Y., Valko, R., Fresser, L., Nepovimova, E., Kuca, K. and Valko, M. (2025). Interplay of oxidative stress and antioxidant mechanisms in cancer development and progression. Archives of Toxicology, 1-47. [Google Scholar]
Jakob, U. and Reichmann, D. (2024). Redox regulation in biology: molecular mechanisms and physiological significance. Nature Reviews Molecular Cell Biology, 25(8), 567–585. [Google Scholar]
Ighodaro, O.M. and Akinloye, O.A. (2018). First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria Journal of Medicine, 54(4), 287–293. [Google Scholar]
Dang, C.V., Li, F. and Lee, L.A. (2005). Could MYC induction of mitochondrial biogenesis be linked to ROS production and genomic instability? Cell Cycle, 4(11), 1465–1466. [Google Scholar]
Barjaktarovic, Z., Merl-Pham, J., Braga-Tanaka, I., Tanaka, S., Hauck, S.M., Saran, A., Mancuso, M., Atkinson, M.J., Tapio, S. and Azimzadeh, O. (2019). Hyperacetylation of cardiac mitochondrial proteins is associated with metabolic impairment and sirtuin downregulation after chronic total body irradiation of ApoE-/- mice. International Journal of Molecular Sciences, 20(20), 5239. [Google Scholar]
Rojo de la Vega, M., Chapman, E. and Zhang, D.D. (2018). NRF2 and hallmarks of cancer. Cancer Cell, 34(1), 21–43. [Google Scholar]
Ren, X., Zou, L., Zhang, X., Branco, V., Wang, J., Carvalho, C., Holmgren, A. and Lu, J. (2017). Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system. Antioxidants & Redox Signaling, 27, 989–1010. [Google Scholar]
EU, A. and AO, N. (2024). Targeting oxidative stress in cancer management: The role of antioxidant phytochemicals. KIU Journal of Health Sciences, 4(2), 1–10.. [Google Scholar]
Leon-Gonzalez, A.J., Auger, C. and Schini-Kerth, V.B. (2015). Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochemical Pharmacology, 98(3), 371–380. [Google Scholar]
Nizami, Z.N., Aburawi, H.E., Semlali, A., Muhammad, K. and Iratni, R. (2023). Oxidative stress inducers in cancer therapy: Preclinical and clinical evidence. Antioxidants, 12(6), 1159. [Google Scholar]
Trachootham, D., Alexandre, J. and Huang, P. (2009). Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nature Reviews Drug Discovery, 8(7), 579–591. [Google Scholar]
Li, Y., Wang, J., Zhang, Q. and Chen, W. (2021). Spicy food and chili peppers: Risks and limitations of capsaicin intake. Frontiers in Oncology, 12, 908487. [Google Scholar]
Pandey, K., Tripathi, S.K., Panda, M. and Biswal, B.K. (2020). Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway. Toxicology in Vitro, 65, 104788. [Google Scholar]
Hornsveld, M. and Dansen, T.B. (2016). The hallmarks of cancer from a redox perspective. Antioxidants & Redox Signaling, 25(6), 300–325. [Google Scholar]
Chen, G., Wang, F., Trachootham, D. and Huang, P. (2010). Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion, 10(6), 614–625. [Google Scholar]
Wang, L., Xu, Z. and Li, W. (2020). Prooxidant therapy in cancer: Mechanisms and challenges. Redox Biology, 28, 101218. [Google Scholar]
Trachootham, D., Alexandre, J. and Huang, P. (2009). Targeting cancer cells by ROS-mediated mechanisms. Nature Reviews Drug Discovery, 8(7), 579–591. [Google Scholar]
Gupta, R., Singh, P. and Sharma, A. (2021). Clinical applications of oxidative therapy: Arsenic trioxide and menadione in oncology. Cancer Treatment Reviews, 98, 102218. [Google Scholar]
Chen, Q., Hou, Y., Li, D., Ding, Z., Xu, X., Hao, B., Xia, Q., Li, M. and Fan, L. (2022). Berberine induces non-small cell lung cancer apoptosis via the activation of the ROS/ASK1/JNK pathway. Annals of Translational Medicine, 10(8), 485. [Google Scholar]
Zhu, H., Li, J. and Cao, D. (2021). Transition metals, redox reactions and oxidative stress in cancer. Metallomics, 13(10), mkab052. [Google Scholar]
Perez, C., Hernandez, M. and Romero, A. (2020). Flavonoids and terpenoids as pro-oxidants in cancer cell death. Antioxidants & Redox Signaling, 33(9), 576–591. [Google Scholar]
Sato, K., Tanaka, Y. and Yamamoto, T. (2019). Disrupting redox homeostasis: mitochondrial pathways of phytochemical-induced apoptosis. Molecular Biology Reports, 46(5), 5339–5349. [Google Scholar]
Yuan, J. and Mao, B. (2022). Chemotherapeutic drugs as prooxidants. Cancer Chemotherapy and Pharmacology, 89(2), 187–201. [Google Scholar]
Nguyen, T., Choi, D. and Yoon, G. (2023). Natural phytochemicals as pro-oxidants in cancer therapy. Phytomedicine, 115, 154737. [Google Scholar]
Srivastava, S.K. (2013). Role of capsaicin in oxidative stress and cancer. Springer Netherlands. [Google Scholar]
Balasubramanyam, M., Koteswari, A.A., Kumar, R.S. et al. (2003). Curcumin-induced inhibition of cellular reactive oxygen species generation: Novel therapeutic implications. Journal of Biosciences, 28, 715–721. [Google Scholar]
Sahebkar, A. (2016). Curcumin: A natural multitarget treatment for pancreatic cancer. Integrative Cancer Therapies, 15(3), 333–334. [Google Scholar]
Park, S., Cho, D.H., Andera, L., Suh, N. and Kim, I. (2013). Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins. Molecular and Cellular Biochemistry, 383(1), 3948. [Google Scholar]
Wu, J., Ibtisham, F., Niu, Y.F., Wang, Z., Li, G.H., Zhao, Y. and An, L. (2019). Curcumin inhibits heat- induced oxidative stress by activating the MAPK-Nrf2/ARE signaling pathway in chicken fibroblasts cells. Journal of Thermal Biology, 79, 112–119. [Google Scholar]
Timoshnikov, V.A., Slepneva, I.A., Chinak, O.A., Selyutina, O.Y. and Polyakov, N.E. (2024). Cytotoxic and ROS generation activity of anthraquinones chelate complexes with metal ions. BioMetals, 37(6), 1643–1656. [Google Scholar]
Huang, X.Z., Wang, J., Huang, C., Chen, Y.Y., Shi, G.Y., Hu, Q.S. and Yi, J. (2008). Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: The mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biology & Therapy, 7(3), 468–475. [Google Scholar]
Sui, J.Q. et al. (2014). Emodin inhibits breast cancer cell proliferation through the ERa-MAPK/Akt-cyclin D1/Bcl-2 signaling pathway. Asian Pacific Journal of Cancer Prevention, 15(15), 6247–6251. [Google Scholar]
Saunders, I.T., Mir, H., Kapur, N. and Singh, S. (2019). Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell International, 19(1), 98. [Google Scholar]
Liu, J. et al. (2014). p38 MAPK signaling mediates mitochondrial apoptosis in cancer cells induced by oleanolic acid. Asian Pacific Journal of Cancer Prevention, 15(11), 4519–4525. [Google Scholar]
Wei, J. et al. (2013). Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. Journal of Applied Toxicology, 33(8), 756–765. [Google Scholar]
Ziberna, L., Samec, D., Mocan, A., Nabavi, S.F., Bishayee, A., Farooqi, A.A. and Nabavi, S.M. (2017). Oleanolic acid alters multiple cell signaling pathways: Implication in cancer prevention and therapy. International Journal of Molecular Sciences, 18(3), 643. [Google Scholar]
Liu, J. et al. (2016). ERK inhibition sensitizes cancer cells to oleanolic acid-induced apoptosis through ERK/Nrf2/ROS pathway. Tumour Biology, 37(6), 8181–8187. [Google Scholar]
Kim, G.J. et al. (2018). Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice. Oncotarget, 9(41), 26370–26386. [Google Scholar]
Kim, M.Y., Trudel, L.J. and Wogan, G.N. (2009). Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide and caspase activation. Anticancer Research, 29(10), 3733–3740. [Google Scholar]
Pramanik, K.C., Boreddy, S.R. and Srivastava, S.K. (2011). Role of mitochondrial electron transport chain complexes in capsaicin-mediated oxidative stress leading to apoptosis. [Google Scholar]
Sanchez, A.M., Malagarie-Cazenave, S., Olea, N. et al. (2007). Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis, 12, 20132024. [Google Scholar]
Hsu, Y.L., Cho, C.Y., Kuo, P.L. and Lin, C.C. (2006). Plumbagin induces apoptosis and cell-cycle arrest in A549 cells through ROS generation and p53 activation. Journal of Pharmacology and Experimental Therapeutics, 318(2), 484–494. [Google Scholar]
Padhye, S., Dandawate, P., Yusufi, M., Ahmad, A. and Sarkar, F.H. (2012). Perspectives on medicinal properties of plumbagin and its analogs. Medicinal Research Reviews, 32(6), 1131–1158. [Google Scholar]
Powolny, A.A. and Singh, S.V. (2008). Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Pharmaceutical Research, 25, 2171–2180. [Google Scholar]
Ahmad, A., Banerjee, S., Wang, Z., Kong, D., Majumdar, A.P.N. and Sarkar, F.H. (2008). Plumbagin- induced apoptosis of human pancreatic cancer cells is mediated by ROS-dependent inhibition of the NF-kB pathway. Molecular Cancer Therapeutics, 7(9), 2672–2681. [Google Scholar]
Rauf, A., Abu-Izneid, T., Khalil, A.A., Imran, M., Shah, Z.A., Emran, T.B., Mitra, S., Khan, Z., Alhumaydhi, F.A., Aljohani, A.S.M., Khan, I., Rahman, M.M., Jeandet, P. and Gondal, T.A. (2021). Berberine as a potential anticancer agent: A comprehensive review. Molecules, 26(23), 7368. [Google Scholar]
Han, C., Wu, Y., Rong, J., Xia, Q. and Du, D. (2025). Unveiling the emerging role of xanthine oxidase in acute pancreatitis: beyond reactive oxygen species. Antioxidants, 14(1), 95. [Google Scholar]
Lin, C., Yang, X., Li, H., Zou, Y., Mohammad, I.S., Rong, H. and Hu, H. (2021). Self-assembled nanomedicine combining a berberine derivative and doxorubicin for enhanced antitumor and antimetastatic efficacy via mitochondrial pathways. Nanoscale, 13(13), 6605–6623. [Google Scholar]
Baeza-Morales, A., Medina-Garcia, M., Martinez-Peinado. P., Pascual-Garcia, S., Pujalte-Satorre, C., Lopez-Jaen, A.B., Martinez-Espinosa, R.M. and Sempere-Ortells, J.M. (2024). The antitumour mechanisms of carotenoids: A comprehensive review. Antioxidants, 13(9), 1060. [Google Scholar]
Shin, J., Song, M.H., Oh, J.W., Keum, Y.S. and Saini, R.K. (2020). Pro-oxidant actions of carotenoids in triggering apoptosis of cancer cells: A review of emerging evidence. Antioxidants, 9(6), 532. [Google Scholar]
Fiedor, J. and Burda, K. (2014). Potential role of carotenoids as antioxidants in human health and disease. Nutrients, 6(2), 466–488. [Google Scholar]
Jaganathan, S.K. and Supriyanto, E. (2011). Apoptotic effect of eugenol in human colon cancer cell lines. Human & Experimental Toxicology, 30(9), 1072–1086. [Google Scholar]
Damasceno, R.O.S., Pinheiro, J.L.S., Rodrigues, L.H.M., Gomes, R.C., Duarte, A.B.S., Emidio, J.J. and de Sousa, D.P. (2024). Anti-inflammatory and antioxidant activities of eugenol: An update. Pharmaceuticals, 17(11), 1505. [Google Scholar]
Bezerra, D.P., Militao, G.C.G., De Morais, M.C. and De Sousa, D.P. (2017). The dual antioxidant/prooxidant effect of eugenol and its action in cancer development and treatment. Nutrients, 9(12), 1367. [Google Scholar]
Mohanty, C., Das, M. and Sahoo, S.K. (2012). Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opinion on Drug Delivery, 9(11), 1347–1364. [Google Scholar]
Ribeiro, M., Pedrosa, R. and Silva, V. (2022). Biological properties and safety of eugenol. International Journal of Molecular Sciences, 22(7), 3671. [Google Scholar]
Liou, G.Y. and Storz, P. (2010). Reactive oxygen species in cancer. Free Radical Research, 44(5), 479–496. [Google Scholar]
Zhang, Q., Li, R. and Wang, Y. (2022). The versatile emodin: Pharmacology and toxicity. International Journal of Biological Sciences, 18, 3498–3515. [Google Scholar]
Zhao, Y., Zhang, X. and Liu, W. (2023). Mechanisms of anthracycline-induced cardiotoxicity. Frontiers in Pharmacology, 14, 1109823. [Google Scholar]
Dasari, S., Tchounwou, P.B. and Ndebele, K. (2022). Cisplatin in cancer therapy: Molecular mechanisms of action and chemoresistance. Frontiers in Oncology, 12, 850560. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.